Renata D.
- Country
- Romania
- Department
- Clinica Oncologie Medicala
Research Overview
Data & Insights
Has run more than one trial at 0 of 51 partner sites.
Specializations
Non‑Small Cell Lung Cancer
The investigator concentrates on metastatic Non‑Small Cell Lung Cancer lacking actionable genomic alterations, evaluating PD-1 inhibitor strategies combined with chemotherapy.
- PD-1 inhibition
- Combination immunotherapy
- Biomarker‑negative disease
- First‑line treatment
- Objective response assessment
Outcome measures include objective response rate evaluated by RECIST v1.1 and blinded independent central review.
Resectable High‑Risk Locally Advanced Cutaneous Squamous Cell Carcinoma
The investigator explores Pembrolizumab as adjuvant therapy for patients with surgically resected, high‑risk Cutaneous Squamous Cell Carcinoma, aiming to improve recurrence‑free survival.
- Adjuvant immunotherapy
- Recurrence‑free survival
- High‑risk surgical cohorts
- Biopsy‑confirmed outcomes
- Local disease control
Research emphasizes long‑term disease‑free intervals following curative resection.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.